Ivan Horak

Ivan Horak

No open positions remaining
75 year
Health Technology
Commercial Services
Consumer Services

Profile

Dr. Ivan D.
Horak
, MD, is a Chief Executive Officer & Director at Tikva Allocell Pte Ltd., a Member at American Association for Cancer Research, a Member at American Society of Clinical Oncology, Inc., a Member at American Society of Hematology and a Venture Advisor at Israel Biotech Fund.
He is on the Board of Directors at Tikva Allocell Pte Ltd. Dr. Horak was previously employed as a Chief Medical & Scientific Officer by Tessa Therapeutics Ltd, a Chief Scientific Officer by Enzon Pharmaceuticals, Inc., a Chief Scientific Officer & Executive VP by Immunomedics, Inc., a Vice President-Clinical Oncology by Pharmacia Corp., a Director-Oncology Clinical Research & Development by The Janssen Research Foundation, a Principal by American College of Physicians, Inc. /Old/, and a Member by Union for International Cancer Control.
He received his doctorate degree from the University of Commenius.

Ivan Horak active positions

CompaniesPositionStart
Corporate Officer/Principal -
Corporate Officer/Principal -
Corporate Officer/Principal -
Consultant / Advisor -

Former positions of Ivan Horak

CompaniesPositionEnd
Chief Tech/Sci/R&D Officer 04/04/2011
IMMUNOMEDICS, INC. Chief Tech/Sci/R&D Officer 02/09/2005
Corporate Officer/Principal 01/05/2002
The Janssen Research Foundation
Chief Tech/Sci/R&D Officer 01/01/1999
President -
See the detail of Ivan Horak's experience

Training of Ivan Horak

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

79

1st degree connections

12

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies12

Health Technology

Health Technology

Union for International Cancer Control

Health Technology

Consumer Services

Health Services

Commercial Services

Commercial Services

Commercial Services

The Janssen Research Foundation

Health Technology

Finance

40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!